The Meme King of Longevity Now Wants to Sell You Olive Oil

Nir Barzilai, M.D., says large, randomized controlled clinical trials are needed to determine if interventions purporting to promote longevity are effective. Dr. Barzilai is professor of medicine and of genetics, the Ingeborg and Ira Leon Rennert Chair in Aging Research, and director of the Institute for Aging Research at Einstein, and an endocrinologist at Montefiore.

Additional coverage includes The Guardian


Here's How Scientists at the Cutting Edge of Aging Research Are Working to Extend 'Health Span'

Nir Barzilai, M.D., and Sofiya Milman, M.D., M.S., describe their SuperAgers Family Study, which seeks to discover genes that contribute to healthy aging. Dr. Barzilai is professor of medicine and of genetics, the Ingeborg and Ira Leon Rennert Chair in Aging Research, and director of the Institute for Aging Research at Einstein, and an endocrinologist at Montefiore. Dr. Milman is associate professor of medicine and of genetics and director of Human Longevity Studies at Einstein’s Institute for Aging Research and an endocrinologist at Montefiore.


Louise Levy, Who Was Studied for Her Very Long Life, Is Dead at 112

Nir Barzilai, M.D., describes his research on genetic mutations that may slow the effects of aging. Dr. Barzilai is professor of medicine and of genetics, the Ingeborg and Ira Leon Rennert Chair in Aging Research, and director of the Institute for Aging Research at Einstein, and an endocrinologist at Montefiore.

Additional coverage includes CNN


Taurine's Astounding Anti-Aging Powers Raise New Questions

Nir Barzilai, M.D., comments on a study that found the amino acid taurine improved the health and extended the life of mice. Dr. Barzilai is professor of medicine and of genetics, the Ingeborg and Ira Leon Rennert Chair in Aging Research, and director of the Institute for Aging Research at Einstein, and an endocrinologist at Montefiore.

Additional coverage includes The New York Times (login required)


President Biden is Turning 80. Experts Say Age is More Than a Number

Nir Barzilai, M.D., says the age of a candidate should not be the only factor voters consider in an election. Dr. Barzilai is professor of medicine and of genetics, the Ingeborg and Ira Leon Rennert Chair in Aging Research, and director of the Institute for Aging Research at Einstein, and an endocrinologist at Montefiore.


As Billionaires Race to Fund Anti-Aging Projects, a Much-Discussed Trial Goes Overlooked

Nir Barzilai, M.D., discusses the challenges of funding a clinical trial to test the effects of the diabetes drug metformin on delaying age-associated diseases like cancer, diabetes, and heart disease. Dr. Barzilai is professor of medicine and of genetics, the Ingeborg and Ira Leon Rennert Chair in Aging Research and director of the Institute for Aging Research at Einstein, and an endocrinologist at Montefiore.


Can You Fight Aging? Scientists Are Testing Drugs to Help

Nir Barzilai, M.D., talks about plans for a clinical trial to study metformin, a diabetes drug, as an anti-aging medicine that may delay the onset of cardiovascular disease, dementia, and other age-related diseases. Dr. Barzilai is professor of medicine and of genetics, the Ingeborg and Ira Leon Rennert Chair in Aging Research and director of the Institute for Aging Research at Einstein, and an endocrinologist at Montefiore.


Searching for a Fountain of Youth

Nir Barzilai, M.D., talks about his plans for a clinical trial to study metformin, a diabetes drug, to target age-related diseases and to extend both lifespan and health span. Dr. Barzilai is professor of medicine and of genetics, the Ingeborg and Ira Leon Rennert Chair in Aging Research and director of the Institute for Aging Research at Einstein, and an endocrinologist at Montefiore. (Interview begins at 2:45)


Inside the Billionaire-Funded Fight to Conquer Aging—and Cheat Death

Nir Barzilai, M.D., talks about his plans for a clinical trial to study metformin, a diabetes drug, to target age-related diseases. Dr. Barzilai is professor of medicine and of genetics, the Ingeborg and Ira Leon Rennert Chair in Aging Research and director of the Institute for Aging Research at Einstein, and an endocrinologist at Montefiore.


Global Leaders Working On Ways For People To Live Healthy Lives Well Past 100

Nir Barzilai, M.D., a speaker at the Fifth International Vatican Conference, talks about longevity research aimed at delaying the onset of diseases associated with aging and extending both lifespan and health span. Dr. Barzilai is professor of medicine and of genetics, the Ingeborg and Ira Leon Rennert Chair in Aging Research and director of the Institute for Aging Research at Einstein, and an endocrinologist at Montefiore.


Can Some Drugs Delay Aging?

Nir Barzilai, M.D., discusses his proposed clinical trial to test whether the diabetes drug metformin can delay age-related diseases such as cancer and Alzheimer's disease. Dr. Barzilai is professor of medicine and of genetics, the Ingeborg and Ira Leon Rennert Chair in Aging Research, and director of the Institute for Aging Research at Einstein and an endocrinologist at Montefiore.


Women and Men Age Differently—in More Ways Than Just Longevity

Nir Barzilai, M.D., says varying rates of protein level changes are among the biological differences in how men and women age. Dr. Barzilai is the Ingeborg and Ira Leon Rennert Chair of Aging Research and director of the Institute for Aging Research at Einstein and an endocrinologist at Montefiore.


Fight the Coronavirus by Defending the Host

Nir Barzilai, M.D., co-authors an op-ed that calls for a national campaign to combat chronic disease and fund research on drugs that target age-related disease—measures that could help protect vulnerable populations from the ravages of COVID-19. Dr. Barzilai is the Ingeborg and Ira Leon Rennert Chair of Aging Research and director of the Institute for Aging Research at Einstein and an endocrinologist at Montefiore.


To Fight COVID-19, Don't Neglect Immunity and Inflammation

Nir Barzilai, M.D., says vulnerability to COVID-19 increases at around age 55, but that older adults can slow or even reverse their declining immune defenses with an improved diet and exercise regimen. Dr. Barzilai is the Ingeborg and Ira Leon Rennert Chair of Aging Research and director of the Institute for Aging Research at Einstein.


In a Historically Old Presidential Field, Candidates Refuse to Release Health Records

Nir Barzilai, M.D., explains how age is a risk factor for many diseases, but notes a mix of other factors, including genetics and lifestyle, can extend the years one remains free of serious disease. Dr. Barzilai is the Ingeborg and Ira Leon Rennert Chair of Aging Research and director of the Institute for Aging Research at Einstein.